Business · 20/02/2002Updated: 10/17/2026 · 1 min read
Mylan Pharmaceuticals et al.; Withdrawal of Approval of 34 Abbreviated New Drug Applications
Summary
The FDA is withdrawing approval of 34 abbreviated new drug applications after the holders notified the agency that the drug products are no longer marketed, requesting the withdrawal of their approvals.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →